$1.07 USD
General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
TARRYTOWN, N.Y. — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter net income of $1.15 billion.
On a per-share basis, the Tarrytown, New York-based company said it had net income of $10.24. Earnings, adjusted for one-time gains and costs, were $9.53 per share.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $8.32 per share.
The biopharmaceutical company posted revenue of $2.42 billion in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $2.39 billion.
For the year, the company reported profit of $3.51 billion, or $30.52 per share. Revenue was reported as $8.5 billion.
Regeneron shares have risen slightly more than 3% since the beginning of the year, while the Standard & Poor's 500 index has risen 3%. The stock has risen 40% in the last 12 months.
